News > Ready to Restart trials: Serum Institute awaits DCGI nod
Ready to Restart trials: Serum Institute awaits DCGI nod
Rediff.com | 13/09/2020 08:32 AM | Click to read full article
The Serum Institute of India is ready to restart coronavirus vaccine trials - pending permission from the DCGI.
The SII had suspended recruitment for Phase 2 and Phase 3 India trials of the Covishield vaccine - being developed by pharma giant AstraZeneca and the University of Oxford - after concerns over the health of a trial participant in the United Kingdom. Hours earlier AstraZeneca said it had received permission to restart its UK trials.